Clinical trial Recruiting at 2 sites Phase 4 Interventional Ages 18 to 40 Women only

Pain-Selective Epidural Analgesia for Labor Mobility

Official title: Pain Selective Anesthesia for Labor Mobility (PSALM Study): a Randomized Controlled Trial of Combined Lidocaine - Chlorprocaine for Labor Epidural Analgesia

Run by Hadassah Medical Organization · NCT06302257 · Data updated 2026-11-12

This study tests a new epidural approach to block only labor pain so mothers can ambulate and push normally during labor.

Quick facts

PhasePhase 4
Study typeInterventional
Ages18 Years to 40 Years
SexWomen only
Enrollment303 (estimated)
SponsorHadassah Medical Organization
Academic / other
Locations3 sites (Jerusalem and 2 other locations)
StatusRecruiting
StartedMarch 12, 2024
Main results expectedMarch 1, 2028
Study endsMarch 1, 2028
Registry record updatedSeptember 25, 2026
Trial IDNCT06302257 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Pregnant women in early active labor (cervical dilation <5 cm), nulliparous, aged 18-40, singleton vertex pregnancies, BMI <110 kg, gestational age >36 weeks, ASA II, at Hadassah-associated centers.

Probably not a fit

Patients who do not respond to the specific nociceptor-targeted approach or who have contraindications to local anesthetics may not experience benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized controlled trial evaluates a novel method for pain-selective local anesthesia during labor using TRPV1-targeted delivery to nociceptors. By combining membrane-impermeable anesthetics with TRPV1 agonists, the approach aims to block pain fibers while avoiding motor, sensory, or blood pressure side effects. The intervention arms include chlorprocaine, lidocaine, and a lidocaine-chlorprocaine combination, delivered via an epidural route in women in early active labor. Eligible participants are nulliparous, 18-40 years old, with singleton, vertex pregnancies at 36 weeks or more, and specific health criteria. The trial seeks to determine whether this method provides effective pain relief with preserved ability to ambulate and push.

Why it matters

Potential benefit: If successful, patients could experience effective labor pain relief without motor weakness or hypotension, supporting mobility and pushing.

How similar studies have gone: Previous preclinical and early-phase work on nociceptor-selective anesthesia suggests potential, but this approach is novel in the labor epidural context and is being tested in humans.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Nulliparity
* Early active labor, cervical dilatation less than 5 cm,
* Age between 18 to 40,
* American Society of Anesthesiologists physical status class II
* Body weight less than 110 kg,
* Gestational age greater than 36 completed weeks,
* Singleton pregnancy
* Vertex presentation.

Exclusion Criteria:

* Narcotic administration in the previous 3 hours
* Previous uterine surgery
* Pre-eclampsia
* Inability to adequately understand the consent

Where it's running

  • Hadassah Hebrew University Medical Center, POB 12000
    Jerusalem, Israel
    Recruiting
  • Hadassah Mount Scopus
    Jerusalem, Israel
    Recruiting
  • Kaplan Medical Center
    Rehovot, Israel
    Not yet recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

  • Dural Puncture Epidural (DPE) Technique in Labor Analgesia

    This observational study at Ohio State tests whether the DPE method can reliably reveal CSF and improve epidural placement during labor without injecting medication.

    Recruiting Ohio State University · Columbus, Ohio · NCT07704554

  • Midwife-guided Birth Affirmation Cards for Primigravidas

    This study tests whether midwife-guided birth affirmation cards can shorten labor, reduce pain, and improve feelings of control and support for first-time mothers.

    Recruiting KTO Karatay University · Mut, Mersi̇n · NCT07542392

  • Tramadol versus paracetamol versus placebo for pain relief and labor length in first-time mothers

    This trial will try IV tramadol, IV paracetamol, or saline to see which gives better pain relief and changes active labor length for first-time mothers in active labor.

    Recruiting at 2 sites Phase 4 Universidad Nacional Autonoma de Honduras · Tegucigalpa, Francisco Morazán Department and 1 other locations · NCT07440069

  • Left-side versus lying on your back to shorten the active phase of labor

    This trial tests whether staying on your left side instead of lying on your back shortens the active phase of labor for first-time mothers at term.

    Recruiting Universidad Nacional Autonoma de Honduras · Tegucigalpa, Francisco Morazán Department · NCT07411352

  • TENS for pain relief during active labor

    This trial will try using a TENS device versus a sham to see if it lowers pain for first-time moms during the active phase of labor.

    Recruiting at 2 sites Universidad Nacional Autonoma de Honduras · Tegucigalpa, Francisco Morazán Department and 1 other locations · NCT07401147

  • PIEB versus CEI for epidural labor pain relief

    This trial will test whether programmed intermittent epidural boluses (PIEB) or a continuous epidural infusion (CEI), each combined with patient-controlled epidural analgesia (PCEA), works better for pain relief during labor in women having vaginal delivery.

    Recruiting Da Nang Family General Hospital · Da Nang · NCT07395934

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.